Virtus Investment Advisers, Inc. Pfizer Inc Transaction History

Virtus Investment Advisers, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $175,783 - $214,588	4,017 New	4,017 $176,000
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $800,270 - $928,424	-25,079 Closed	0 $0
Q4 2017 Feb 26, 2018	SELL	$33.26 - $35.29 $3.27 Million - $3.47 Million	-98,271 Reduced 79.67%	25,079 $908,000
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $4.1 Million - $4.35 Million	123,350	123,350 $912,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Virtus Investment Advisers, Inc., based on Form 13F filings with the SEC.

Stay updated on Virtus Investment Advisers, Inc. with notifications on news.